CDEK
← All organizations

Tobira Therapeutics, Inc.

For profitContributed to NME
Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Feb 1, 2009

Last known activity

Apr 4, 2017

Acquired by Allergan PLC (2015) → AbbVie on Sep 20, 2016

Timeline

2000s

  1. Jun 1, 2006

    Tobira Therapeutics, Inc.— Founded

2010s

  1. Jan 1, 2015

    Regado Biosciences— Acquired

  2. Sep 20, 2016

    Allergan PLC (2015)— Acquired By

  3. Jun 26, 2019

    AbbVie— Now

Drugs by trial phase (16 distinct, 17 trials)

Phase 3 (1 own, 2 via acquisition)

Phase 2 (2 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (1 direct, 1 total across the full acquisition tree)

Recent trials (19)

Details

Founded
Manalapan, NJ, US Jun 1, 2006
Last known activity
Apr 4, 2017